These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23139725)

  • 1. Plasmonic nanobubbles rapidly detect and destroy drug-resistant tumors.
    Lukianova-Hleb EY; Ren X; Townley D; Wu X; Kupferman ME; Lapotko DO
    Theranostics; 2012; 2(10):976-87. PubMed ID: 23139725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tunable plasmonic nanoprobes for theranostics of prostate cancer.
    Lukianova-Hleb EY; Oginsky AO; Samaniego AP; Shenefelt DL; Wagner DS; Hafner JH; Farach-Carson MC; Lapotko DO
    Theranostics; 2011 Jan; 1():3-17. PubMed ID: 21547151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraoperative diagnostics and elimination of residual microtumours with plasmonic nanobubbles.
    Lukianova-Hleb EY; Kim YS; Belatsarkouski I; Gillenwater AM; O'Neill BE; Lapotko DO
    Nat Nanotechnol; 2016 Jun; 11(6):525-532. PubMed ID: 26878142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmonic nanobubble-enhanced endosomal escape processes for selective and guided intracellular delivery of chemotherapy to drug-resistant cancer cells.
    Lukianova-Hleb EY; Belyanin A; Kashinath S; Wu X; Lapotko DO
    Biomaterials; 2012 Feb; 33(6):1821-6. PubMed ID: 22137124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vivo performance of plasmonic nanobubbles as cell theranostic agents in zebrafish hosting prostate cancer xenografts.
    Wagner DS; Delk NA; Lukianova-Hleb EY; Hafner JH; Farach-Carson MC; Lapotko DO
    Biomaterials; 2010 Oct; 31(29):7567-74. PubMed ID: 20630586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient photothermal spectra of plasmonic nanobubbles.
    Lukianova-Hleb EY; Sassaroli E; Jones A; Lapotko DO
    Langmuir; 2012 Mar; 28(10):4858-66. PubMed ID: 22339620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective and self-guided micro-ablation of tissue with plasmonic nanobubbles.
    Lukianova-Hleb EY; Koneva II; Oginsky AO; La Francesca S; Lapotko DO
    J Surg Res; 2011 Mar; 166(1):e3-13. PubMed ID: 21176913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tunable plasmonic nanobubbles for cell theranostics.
    Lukianova-Hleb EY; Hanna EY; Hafner JH; Lapotko DO
    Nanotechnology; 2010 Feb; 21(8):85102. PubMed ID: 20097970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laser pulse duration is critical for the generation of plasmonic nanobubbles.
    Lukianova-Hleb EY; Volkov AN; Lapotko DO
    Langmuir; 2014 Jul; 30(25):7425-34. PubMed ID: 24916057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective gene transfection of individual cells in vitro with plasmonic nanobubbles.
    Lukianova-Hleb EY; Samaniego AP; Wen J; Metelitsa LS; Chang CC; Lapotko DO
    J Control Release; 2011 Jun; 152(2):286-93. PubMed ID: 21315120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmonic nanobubbles as tunable cellular probes for cancer theranostics.
    Lapotko D
    Cancers (Basel); 2011 Feb; 3(1):802-40. PubMed ID: 21442036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmonic nanobubbles as transient vapor nanobubbles generated around plasmonic nanoparticles.
    Lukianova-Hleb E; Hu Y; Latterini L; Tarpani L; Lee S; Drezek RA; Hafner JH; Lapotko DO
    ACS Nano; 2010 Apr; 4(4):2109-23. PubMed ID: 20307085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On-demand intracellular amplification of chemoradiation with cancer-specific plasmonic nanobubbles.
    Lukianova-Hleb EY; Ren X; Sawant RR; Wu X; Torchilin VP; Lapotko DO
    Nat Med; 2014 Jul; 20(7):778-784. PubMed ID: 24880615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved cellular specificity of plasmonic nanobubbles versus nanoparticles in heterogeneous cell systems.
    Lukianova-Hleb EY; Ren X; Constantinou PE; Danysh BP; Shenefelt DL; Carson DD; Farach-Carson MC; Kulchitsky VA; Wu X; Wagner DS; Lapotko DO
    PLoS One; 2012; 7(4):e34537. PubMed ID: 22509318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optically guided controlled release from liposomes with tunable plasmonic nanobubbles.
    Anderson LJ; Hansen E; Lukianova-Hleb EY; Hafner JH; Lapotko DO
    J Control Release; 2010 Jun; 144(2):151-8. PubMed ID: 20156498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid detection and destruction of squamous cell carcinoma of the head and neck by nano-quadrapeutics.
    Lukianova-Hleb EY; Lapotko DO
    Head Neck; 2015 Oct; 37(10):1547-55. PubMed ID: 25677387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose dependency of pharmacokinetics and therapeutic efficacy of pegylated liposomal doxorubicin (DOXIL) in murine models.
    Gabizon A; Tzemach D; Mak L; Bronstein M; Horowitz AT
    J Drug Target; 2002 Nov; 10(7):539-48. PubMed ID: 12683721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and detection of plasmonic nanobubbles in zebrafish.
    Lukianova-Hleb EY; Santiago C; Wagner DS; Hafner JH; Lapotko DO
    Nanotechnology; 2010 Jun; 21(22):225102. PubMed ID: 20453288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Dynamics Simulation Combined with Near-Field Electromagnetic Analysis for Ultrashort-Pulsed Light-Induced Plasmonic Nanobubbles.
    Dong Q; An W; Zhang Y
    Langmuir; 2024 Feb; 40(8):4198-4206. PubMed ID: 38355291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods for Generation and Detection of Nonstationary Vapor Nanobubbles Around Plasmonic Nanoparticles.
    Lukianova-Hleb EY; Lapotko DO
    Methods Mol Biol; 2017; 1530():165-192. PubMed ID: 28150203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.